140 related articles for article (PubMed ID: 36470432)
1. Emulgel-loaded mannosylated thiolated chitosan-coated silver nanoparticles for the treatment of cutaneous leishmaniasis.
Shakeel M; Kiani MH; Sarwar HS; Akhtar S; Rauf A; Ibrahim IM; Ajalli N; Shahnaz G; Rahdar A; Díez-Pascual AM
Int J Biol Macromol; 2023 Feb; 227():1293-1304. PubMed ID: 36470432
[TBL] [Abstract][Full Text] [Related]
2. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
Afzal I; Sarwar HS; Sohail MF; Varikuti S; Jahan S; Akhtar S; Yasinzai M; Satoskar AR; Shahnaz G
Nanomedicine (Lond); 2019 Feb; 14(4):387-406. PubMed ID: 30688557
[TBL] [Abstract][Full Text] [Related]
3. Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
Sarwar HS; Ashraf S; Akhtar S; Sohail MF; Hussain SZ; Rafay M; Yasinzai M; Hussain I; Shahnaz G
Nanomedicine (Lond); 2018 Jan; 13(1):25-41. PubMed ID: 29173059
[TBL] [Abstract][Full Text] [Related]
4. Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis.
Esfandiari F; Motazedian MH; Asgari Q; Morowvat MH; Molaei M; Heli H
Acta Trop; 2019 Sep; 197():105072. PubMed ID: 31300160
[TBL] [Abstract][Full Text] [Related]
5. Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis.
Esfandiari F; Motazedian MH; Asgari Q; Morowvat MH; Molaei M; Heli H
Acta Trop; 2019 Sep; 197():105045. PubMed ID: 31158341
[TBL] [Abstract][Full Text] [Related]
6. Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Sarwar HS; Sohail MF; Saljoughian N; Rehman AU; Akhtar S; Nadhman A; Yasinzai M; Gendelman HE; Satoskar AR; Shahnaz G
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):521-531. PubMed ID: 29385910
[TBL] [Abstract][Full Text] [Related]
7. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis.
Niroumand U; Motazedian MH; Ahmadi F; Asgari Q; Bahreini MS; Ghasemiyeh P; Mohammadi-Samani S
Sci Rep; 2024 May; 14(1):10073. PubMed ID: 38698123
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis.
Dar MJ; McElroy CA; Khan MI; Satoskar AR; Khan GM
Expert Opin Drug Deliv; 2020 Jan; 17(1):97-110. PubMed ID: 31786952
[No Abstract] [Full Text] [Related]
11. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
12. Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.
Moreno E; Schwartz J; Larrea E; Conde I; Font M; Sanmartín C; Irache JM; Espuelas S
Nanomedicine; 2015 Nov; 11(8):2003-12. PubMed ID: 26282379
[TBL] [Abstract][Full Text] [Related]
13. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
Abamor ES; Allahverdiyev AM
Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive docetaxel-loaded chitosan/thiolated hyaluronic acid polymeric nanoparticles for colorectal cancer.
Noreen S; Pervaiz F; Ijaz M; Hanif MF; Hamza JR; Mahmood H; Shoukat H; Maqbool I; Ashraf MA
Nanomedicine (Lond); 2024 Apr; 19(9):755-777. PubMed ID: 38334078
[No Abstract] [Full Text] [Related]
15. Mannosylated-Chitosan-Coated Andrographolide Nanoliposomes for the Treatment of Hepatitis: In Vitro and In Vivo Evaluations.
Metkar SP; Fernandes G; Nikam AN; Soman S; Birangal S; Seetharam RN; Joshi MB; Mutalik S
Membranes (Basel); 2023 Feb; 13(2):. PubMed ID: 36837696
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major.
Varshosaz J; Arbabi B; Pestehchian N; Saberi S; Delavari M
Int J Biol Macromol; 2018 Feb; 107(Pt A):212-221. PubMed ID: 28867228
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of moxifloxacin HCl-loaded biodegradable chitosan nanoparticles for potential antibacterial and accelerated cutaneous wound healing efficacy.
Hameed M; Rasul A; Latif S; Rasool M; Abbas G; Siddique MI; Waqas MK; Khan IU; Yousaf AM; Shah PA
J Microencapsul; 2022 Jan; 39(1):37-48. PubMed ID: 34919007
[TBL] [Abstract][Full Text] [Related]
18. Silver nanoparticles in situ synthesized by polysaccharides from Sanghuangporus sanghuang and composites with chitosan to prepare scaffolds for the regeneration of infected full-thickness skin defects.
Ran L; Zou Y; Cheng J; Lu F
Int J Biol Macromol; 2019 Mar; 125():392-403. PubMed ID: 30529352
[TBL] [Abstract][Full Text] [Related]
19. Fe3O4
Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
[TBL] [Abstract][Full Text] [Related]
20. Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation.
Jamshaid H; Din FU; Nousheen K; Khan SU; Fatima A; Khan S; Choi HG; Khan GM
Biomater Adv; 2023 Feb; 145():213266. PubMed ID: 36577194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
